Filed: 2/14/2024ACC: 0001214659-24-002827
📋 What this filing means
OCTAGON CAPITAL ADVISORS LP filed this quarterly 13F‑HR report disclosing 33 equity positions with a total reported market value of $624.99M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
33
Positions
$624.99M
Total AUM (reported)
51.17M
Total Shares
Allocation by class
COM$431.57M69.1%
SPONSORED ADS$86.36M13.8%
COM PAR $.01$39.79M6.4%
COM NEW$37.75M6.0%
SHS$28.01M4.5%
COM CL A$1.51M0.2%
Portfolio Concentration
Top 3$278.28M44.5%
4–10$200.61M32.1%
11–25$135.30M21.6%
Rest$10.80M1.7%
Top 3 weight
44.5%
Top 10 weight
76.6%
Voting Authority Distribution
Total shares with voting rights: 51.17M
Sole
Full voting authority
51.17M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole33
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings33
Rows:
APELLIS PHARMACEUTICALS INC
SOLEShares2.81M
TypeSH
Market value$168.03M
26.88%
Sole
2.81M
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares2.67M
TypeSH
Market value$63.15M
10.10%
Sole
2.67M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares2.37M
TypeSH
Market value$47.10M
7.54%
Sole
2.37M
Shared
0.00
None
0.00
INSMED INC
SOLEShares1.28M
TypeSH
Market value$39.79M
6.37%
Sole
1.28M
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares1.87M
TypeSH
Market value$35.68M
5.71%
Sole
1.87M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares706.80K
TypeSH
Market value$28.53M
4.57%
Sole
706.80K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares707.53K
TypeSH
Market value$28.06M
4.49%
Sole
707.53K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares2.49M
TypeSH
Market value$28.01M
4.48%
Sole
2.49M
Shared
0.00
None
0.00
ALPINE IMMUNE SCIENCES INC
SOLEShares1.24M
TypeSH
Market value$23.66M
3.79%
Sole
1.24M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares414K
TypeSH
Market value$16.87M
2.70%
Sole
414K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares2.06M
TypeSH
Market value$16.40M
2.62%
Sole
2.06M
Shared
0.00
None
0.00
AN2 THERAPEUTICS INC
SOLEShares664.58K
TypeSH
Market value$13.62M
2.18%
Sole
664.58K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares620K
TypeSH
Market value$13.50M
2.16%
Sole
620K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares273.29K
TypeSH
Market value$11.51M
1.84%
Sole
273.29K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares792.95K
TypeSH
Market value$10.55M
1.69%
Sole
792.95K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares116K
TypeSH
Market value$9.68M
1.55%
Sole
116K
Shared
0.00
None
0.00
ANNEXON INC
SOLEShares2.05M
TypeSH
Market value$9.31M
1.49%
Sole
2.05M
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares403.69K
TypeSH
Market value$9.14M
1.46%
Sole
403.69K
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares9.19M
TypeSH
Market value$8.38M
1.34%
Sole
9.19M
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares292K
TypeSH
Market value$7.26M
1.16%
Sole
292K
Shared
0.00
None
0.00
GLYCOMIMETICS INC
SOLEShares3M
TypeSH
Market value$7.08M
1.13%
Sole
3M
Shared
0.00
None
0.00
GRACELL BIOTECHNOLOGIES INC
SOLEShares596.61K
TypeSH
Market value$5.99M
0.96%
Sole
596.61K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares554K
TypeSH
Market value$5.76M
0.92%
Sole
554K
Shared
0.00
None
0.00
RENEO PHARMACEUTICALS INC
SOLEShares2.25M
TypeSH
Market value$3.60M
0.58%
Sole
2.25M
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares4.47M
TypeSH
Market value$3.53M
0.56%
Sole
4.47M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APELLIS PHARMACEUTICALS INCSOLE | COM | 2.81M | SH | $168.03M 26.88% | 2.81M | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 2.67M | SH | $63.15M 10.10% | 2.67M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 2.37M | SH | $47.10M 7.54% | 2.37M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 1.28M | SH | $39.79M 6.37% | 1.28M | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 1.87M | SH | $35.68M 5.71% | 1.87M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 706.80K | SH | $28.53M 4.57% | 706.80K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 707.53K | SH | $28.06M 4.49% | 707.53K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 2.49M | SH | $28.01M 4.48% | 2.49M | 0.00 | 0.00 |
ALPINE IMMUNE SCIENCES INCSOLE | COM | 1.24M | SH | $23.66M 3.79% | 1.24M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 414K | SH | $16.87M 2.70% | 414K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 2.06M | SH | $16.40M 2.62% | 2.06M | 0.00 | 0.00 |
AN2 THERAPEUTICS INCSOLE | COM | 664.58K | SH | $13.62M 2.18% | 664.58K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 620K | SH | $13.50M 2.16% | 620K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 273.29K | SH | $11.51M 1.84% | 273.29K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 792.95K | SH | $10.55M 1.69% | 792.95K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 116K | SH | $9.68M 1.55% | 116K | 0.00 | 0.00 |
ANNEXON INCSOLE | COM | 2.05M | SH | $9.31M 1.49% | 2.05M | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COM | 403.69K | SH | $9.14M 1.46% | 403.69K | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 9.19M | SH | $8.38M 1.34% | 9.19M | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM | 292K | SH | $7.26M 1.16% | 292K | 0.00 | 0.00 |
GLYCOMIMETICS INCSOLE | COM | 3M | SH | $7.08M 1.13% | 3M | 0.00 | 0.00 |
GRACELL BIOTECHNOLOGIES INCSOLE | SPONSORED ADS | 596.61K | SH | $5.99M 0.96% | 596.61K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 554K | SH | $5.76M 0.92% | 554K | 0.00 | 0.00 |
RENEO PHARMACEUTICALS INCSOLE | COM | 2.25M | SH | $3.60M 0.58% | 2.25M | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM | 4.47M | SH | $3.53M 0.56% | 4.47M | 0.00 | 0.00 |
Page 1 of 2